Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$37.35 - $48.3 $1,045 - $1,352
-28 Reduced 18.3%
125 $6,000
Q1 2022

May 11, 2022

BUY
$31.97 - $41.06 $2,301 - $2,956
72 Added 88.89%
153 $6,000
Q4 2021

Jan 10, 2022

BUY
$31.82 - $40.75 $1,845 - $2,363
58 Added 252.17%
81 $3,000
Q3 2021

Nov 24, 2021

BUY
$38.47 - $46.42 $884 - $1,067
23 New
23 $1,000
Q4 2020

Jan 15, 2021

SELL
$25.81 - $43.62 $77 - $130
-3 Closed
0 $0
Q2 2020

Jul 10, 2020

BUY
$16.25 - $26.81 $48 - $80
3 New
3 $0
Q2 2019

Aug 07, 2019

SELL
$14.75 - $17.26 $5,900 - $6,904
-400 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$17.06 - $21.2 $4,265 - $5,300
250 Added 166.67%
400 $8,000
Q4 2017

Feb 14, 2018

BUY
$16.75 - $20.8 $2,512 - $3,120
150
150 $3,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.